Inhibition of ICAM1 diminishes stemness and enhances antitumor immunity in glioblastoma via β-catenin/PD-L1 signaling
Meixia Guo(Henan University), Jinlong Yin(Henan University)
Cited by 5
Related Papers
IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis
|Nature Communications|2023|45
CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells
|Cell Reports Medicine|2024|14
P4HB maintains Wnt-dependent stemness in glioblastoma stem cells as a precision therapeutic target and serum marker
|Oncogenesis|2024|7
Synthesis of selective BCL-XL PROTAC and potent antitumor activity in glioblastoma
|Cell Reports Physical Science|2025|3